7 Pulmonology Headlines You Missed in September 2025

September 2025 brought a mix of advances and setbacks in pulmonology, with new clinical trial readouts and regulatory updates highlighting the evolving landscape of respiratory care. Landmark data in idiopathic pulmonary fibrosis, sarcoidosis, and emphysema underscored both the promise of novel therapies and the ongoing challenges of treating progressive lung disease. At the same time, large-scale studies shed light on the intergenerational effects of smoke exposure, reinforcing the long-term importance of preventive measures in public health.